Effect of tetrahydrobiopterin on Phe/Tyr ratios and variation in Phe levels in tetrahydrobiopterin responsive PKU patients

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 89-92

  Humphrey, Maureen ^a   Nation, Judy ^a   Francis, Ivan ^b   Boneh, Avihu ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b Newborn Screening Laboratory   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Phenylalanine; Phenylalanine tyrosine ratio; Phenylketonuria (PKU); Tetrahydrobiopterin; Tyrosine

Indexed keywords

PHENYLALANINE; TETRAHYDROBIOPTERIN; TYROSINE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; HUMAN; MAJOR CLINICAL STUDY; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEWBORN; PHENYLKETONURIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

BIOPTERIN; HUMANS; INFANT, NEWBORN; PHENYLALANINE; PHENYLKETONURIAS; TYROSINE;

EID: 80052537844     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.05.011     Document Type: Article

References (16)

1. Burgard P., Bremer H.J., Buhrdel P., Clemens P.C., Monch E., Przyrembel H., Trefz F.K., Ullrich K. Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur. J. Pediatr. 1999, 158:46-54.
2. Walter J.H., White F.J., Hall S.K., MacDonald A., Rylance G., Boneh A., Francis D.E., Shortland G.J., Schmidt M., Vail A. How practical are recommendations for dietary control in phenylketonuria?. Lancet 2002, 360:55-57.
3. Anonymous Phenylketonuria (PKU): screening and management. NIH Consens. Statement 2000, 17:1-33.
4. Abadie V., Berthelot J., Feillet F., Maurin N., Mercier A., Ogier de Baulny H., de Parscau L. Management of phenylketonuria and hyperphenylalaninemia: the French guidelines. Arch. Pediatr. 2005, 12:594-601.
5. Kure S., Hou D.C., Ohura T., Iwamoto H., Suzuki S., Sugiyama N., Sakamoto O., Fujii K., Matsubara Y., Narisawa K. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 1999, 135:375-378.
6. Spaapen L.J., Bakker J.A., Velter C., Loots W., Rubio-Gozalbo M.E., Forget P.P., Dorland L., De Koning T.J., Poll-The B.T., Ploos van Amstel H.K., Bekhof J., Blau N., Duran M., Rubio-Gonzalbo M.E. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates. J. Inherit. Metab. Dis. 2001, 24:352-358.
7. Muntau A.C., Roschinger W., Habich M., Demmelmair H., Hoffmann B., Sommerhoff C.P., Roscher A.A. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med. 2002, 347:2122-2132.
8. Bernegger C., Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002. Mol. Genet. Metab. 2002, 77:304-313.
9. Blau N., Scriver C.R. New approaches to treat PKU: how far are we?. Mol. Genet. Metab. 2004, 81:1-2.
10. Boneh A., Francis D.E., Humphrey M., Upton H.J., Peters H.L. Three-year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria. J. Paediatr. Child Health 2006, 42:496-498.
11. Steinfeld R., Kohlschutter A., Ullrich K., Lukacs Z. Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria. J. Inherit. Metab. Dis. 2004, 27:449-453.
12. Desviat L.R., Perez B., Belanger-Quintana A., Castro M., Aguado C., Sanchez A., Garcia M.J., Martinez-Pardo M., Ugarte M. Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype. Mol. Genet. Metab. 2004, 83:157-162.
13. Luciana M., Sullivan J., Nelson C.A. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child. Dev. 2001, 72:1637-1652.
14. Anastasoaie V., Kurzius L., Forbes P., Waisbren S. Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Mol. Genet. Metab. 2008, 95:17-20.
15. Ceglarek U., Muller P., Stach B., Buhrdel P., Thiery J., Kiess W. Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin. Chem. Lab. Med. 2002, 40:693-697.
16. Chace D.H., Sherwin J.E., Hillman S.L., Lorey F., Cunningham G.C. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24hours. Clin. Chem. 1998, 44:2405-2409.